<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00973154</url>
  </required_header>
  <id_info>
    <org_study_id>STEP</org_study_id>
    <nct_id>NCT00973154</nct_id>
  </id_info>
  <brief_title>Corticosteroid Treatment for Community-Acquired Pneumonia - The STEP Trial</brief_title>
  <acronym>STEP</acronym>
  <official_title>Corticosteroid Treatment for Community-Acquired Pneumonia A Randomized, Double-blind Study- The STEP Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Kantonsspital Aarau</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kantonsspital Liestal</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Basel, Switzerland</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background: An intact hypothalami-pituitary-adrenal (HPA) axis with an effective
      intracellular anti-inflammatory activity of glucocorticoids is indispensable for host
      survival during stress upon exposure to an infectious agent. Community-acquired pneumonia
      (CAP) is characterized by significant mortality and increased circulating inflammatory
      cytokines. Despite adequate antimicrobial therapy mortality rates for CAP have not changed
      over several decades. The use of corticosteroids in patients with CAP is inconclusive.

      Study aim: To compare a 7 days treatment with prednisone and placebo in patients with
      community-acquired pneumonia with respect to time to clinical stability.

      Study hypothesis: The investigators hypothesize that use of corticosteroids will lead to a
      25% relative risk reduction for death and clinical instability.

      Study type: randomized double blind intervention study

      Patients: 800 patients with community-acquired pneumonia
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2009</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">July 2014</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to clinical stability</measure>
    <time_frame>30 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Side effects of corticosteroids, mortality, recurrence</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">800</enrollment>
  <condition>Community-acquired Pneumonia</condition>
  <arm_group>
    <arm_group_label>Prednisone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Drug</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Prednisone</intervention_name>
    <description>50mg per day of prednisone orally for 7 days versus placebo</description>
    <arm_group_label>Prednisone</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients 18 years of age or older admitted for hospitalization from the community or a
             nursing home with CAP.

          2. CAP will be defined by a new infiltrate on chest radiograph and the presence of one or
             several of the following acute respiratory signs or symptoms:

               -  cough

               -  sputum production

               -  dyspnea

               -  core body temperature &gt;38.0° C

               -  auscultatory findings of abnormal breath sounds and rales

               -  leukocyte count &gt;10 or &lt;4 x 109 cells L-1 (1)

        Exclusion Criteria:

          1. Patients or family members unable to give written informed consent, e.g. with severe
             dementia.

          2. Patients with active intravenous drug use.

          3. Severe immunosuppression (e.g. patients infected with human immunodeficiency virus
             infection and a CD4 count below 350 x 109/L, patients on immunosuppressive therapy
             after solid organ transplantation and neutropenic patients with neutrophil count &lt; 500
             x 109/L and patients under chemotherapy with neutrophils 500-1000 x 109/L with an
             expected decrease to values &lt; 500 x 109/L); patients with cystic fibrosis as well as
             patients with active tuberculosis.

          4. Patients with acute burn injury

          5. Patients with acute gastrointestinal bleeding within 3 months of the current
             hospitalization

          6. Patients with an acute concomitant condition requiring more than 0.5mg/kg/d prednisone
             equivalent

          7. Pregnancy or breast feeding

          8. Patients with known adrenal insufficiency
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mirjam Christ-Crain, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Basel, Switzerland</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medizinische Klinik, Kantonsspital Liestal</name>
      <address>
        <city>Liestal</city>
        <state>BL</state>
        <zip>4410</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medicine Interne, Hôpital du Jura, site de Delémont</name>
      <address>
        <city>Delémont</city>
        <state>JU</state>
        <zip>2800</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kantonsspital Aarau</name>
      <address>
        <city>Aarau</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Basel</name>
      <address>
        <city>Basel</city>
        <zip>4031</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Inselspital</name>
      <address>
        <city>Bern</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bruderholzspital</name>
      <address>
        <city>Bruderholz</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bürgerspital</name>
      <address>
        <city>Solothurn</city>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 7, 2009</study_first_submitted>
  <study_first_submitted_qc>September 8, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 9, 2009</study_first_posted>
  <last_update_submitted>April 20, 2015</last_update_submitted>
  <last_update_submitted_qc>April 20, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 21, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Basel, Switzerland</investigator_affiliation>
    <investigator_full_name>Mirjam Christ-Crain</investigator_full_name>
    <investigator_title>Prof. Dr. med. Leitende Aerztin</investigator_title>
  </responsible_party>
  <keyword>Pneumonia</keyword>
  <keyword>Corticosteroids</keyword>
  <keyword>clinical stability</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumonia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Prednisone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

